Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19- targeted CAR T-cell therapy with memorial sloan kettering cancer center. The company also offers clinical and preclinical development programs that utilize multiple isotopes, including Actinium-225, Iodine-131, and Lutetium-177 directed at multiple validated cancer targets, including CD45, CD33, CD38, CD47, HER2, and HER3 for targeted conditioning prior to cell and gene therapies, such as bone marrow transplant and cancer therapeutics as single agents or in combination with other therapeutic modalities. It has collaboration with Astellas Pharma, Inc. to develop theranostics for solid tumor indications; EpicentRx, Inc that focuses on a novel CD47 immunotherapy targeted radiotherapy; and AVEO Oncology that focuses on developing a HER3 targeting ARC for solid tumors. The company was incorporated in 2000 and is based in New York, New York.
$54.52M
Mr. Sandesh C. Seth M.B.A., M.S., MBA
32.00
New York, NY
Mar 26, 2014
-1.16
$-1.51
8.84
8.95
-52,620.99%
-1.31
-0.03
1.28
715.40
8.95
-47.43%
-101.69%
Similar stocks (19)
Exelixis, Inc.
EXEL
Viking Therapeutics, Inc.
VKTX
Madrigal Pharmaceuticals, Inc.
MDGL
Axsome Therapeutics, Inc.
AXSM
TG Therapeutics, Inc.
TGTX
Cassava Sciences, Inc.
SAVA
Rigel Pharmaceuticals, Inc.
RIGL
Sangamo Therapeutics, Inc.
SGMO
Seres Therapeutics, Inc.
MCRB
Kodiak Sciences Inc.
KOD
Annovis Bio, Inc.
ANVS
Fortress Biotech, Inc.
FBIO
Eyenovia, Inc.
EYEN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Ocuphire Pharma, Inc.
OCUP
MiNK Therapeutics, Inc.
INKT
BioXcel Therapeutics, Inc.
BTAI
Cognition Therapeutics, Inc.
CGTX
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (20)
Vanguard Russell 2000 Growth Index Fund
VTWG
0.02%
iShares Micro-Cap ETF
IWC
0.01391%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00407%
iShares Russell 2000 ETF
IWM
0.00203%
ProShares Ultra Russell2000
UWM
7.65579673346695e-4%
ProShares UltraPro Russell2000
URTY
3.7730389414046463e-4%
ProShares Hedge Replication ETF
HDG
3.211182036682154e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.8646e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (19)
Exelixis, Inc.
EXEL
Viking Therapeutics, Inc.
VKTX
Madrigal Pharmaceuticals, Inc.
MDGL
Axsome Therapeutics, Inc.
AXSM
TG Therapeutics, Inc.
TGTX
Cassava Sciences, Inc.
SAVA
Rigel Pharmaceuticals, Inc.
RIGL
Sangamo Therapeutics, Inc.
SGMO
Seres Therapeutics, Inc.
MCRB
Kodiak Sciences Inc.
KOD
Annovis Bio, Inc.
ANVS
Fortress Biotech, Inc.
FBIO
Eyenovia, Inc.
EYEN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Ocuphire Pharma, Inc.
OCUP
MiNK Therapeutics, Inc.
INKT
BioXcel Therapeutics, Inc.
BTAI
Cognition Therapeutics, Inc.
CGTX
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (20)
Vanguard Russell 2000 Growth Index Fund
VTWG
0.02%
iShares Micro-Cap ETF
IWC
0.01391%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00407%
iShares Russell 2000 ETF
IWM
0.00203%
ProShares Ultra Russell2000
UWM
7.65579673346695e-4%
ProShares UltraPro Russell2000
URTY
3.7730389414046463e-4%
ProShares Hedge Replication ETF
HDG
3.211182036682154e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.8646e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%